論文

査読有り 国際誌
2020年7月26日

A Follow-Up Report of an Infant Born to a Mother Receiving Tamoxifen

Case Reports in Pediatrics
  • Yuki Okada
  • ,
  • Daisuke Hitaka
  • ,
  • Takahiro Kido
  • ,
  • Yu Kanai
  • ,
  • Kumi Konishi
  • ,
  • Kosuke Doki
  • ,
  • Nobuko Katayama
  • ,
  • Masato Homma
  • ,
  • Yayoi Miyazono
  • ,
  • Hidetoshi Takada

2020
開始ページ
2056756
終了ページ
2056756
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1155/2020/2056756

Tamoxifen, an estrogen receptor antagonist, is contraindicated in pregnant women due to its teratogenic activity. In the present study, we report the case of an infant whose mother received tamoxifen for breast cancer while unaware of the pregnancy. The infant, born at 29 weeks and 6 days of gestational age with a birth weight of 1664 g, had no congenital anomalies. This case presents detailed information on the development of an infant with placental transfer of tamoxifen. The infant has grown and developed normally throughout a 5-year follow-up period, but long-term vigilance continues.

リンク情報
DOI
https://doi.org/10.1155/2020/2056756
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/32774971
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399775
ID情報
  • DOI : 10.1155/2020/2056756
  • ORCIDのPut Code : 77908009
  • PubMed ID : 32774971
  • PubMed Central 記事ID : PMC7399775

エクスポート
BibTeX RIS